Definition and classification of cancer cachexia: an international consensus

…, I Bosaeus, E Bruera, RL Fainsinger, A Jatoi… - The lancet …, 2011 - thelancet.com
To develop a framework for the definition and classification of cancer cachexia a panel of
experts participated in a formal consensus process, including focus groups and two Delphi …

Cachexia: a new definition

…, J Argilés, C Bales, V Baracos, D Guttridge, A Jatoi… - Clinical nutrition, 2008 - Elsevier
On December 13th and 14th a group of scientists and clinicians met in Washington, DC, for
the cachexia consensus conference. At the present time, there is no widely agreed upon …

[PDF][PDF] Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study

A Jatoi, HE Windschitl, CL Loprinzi… - Journal of clinical …, 2002 - researchgate.net
Purpose: To determine whether dronabinol admin-istered alone or with megestrol acetate
was more, less, or equal in efficacy to single-agent megestrol acetate for palliating cancer-…

Sarcopenia: a time for action. An SCWD position paper

…, W Doehner, SB Heymsfield, A Jatoi… - Journal of cachexia …, 2019 - Wiley Online Library
The term sarcopenia was introduced in 1988. The original definition was a “muscle loss” of
the appendicular muscle mass in the older people as measured by dual energy x‐ray …

Older adult participation in cancer clinical trials: a systematic review of barriers and interventions

…, HJ Cohen, HB Muss, A Jatoi… - CA: a cancer journal …, 2021 - Wiley Online Library
Cancer is a disease of aging and, as the world's population ages, the number of older persons
with cancer is increasing and will make up a growing share of the oncology population in …

Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies

S Dodson, VE Baracos, A Jatoi, WJ Evans… - Annual review of …, 2011 - annualreviews.org
Cancer cachexia is a complex metabolic condition characterized by loss of skeletal muscle.
Common clinical manifestations include muscle wasting, anemia, reduced caloric intake, …

A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

A Jatoi, N Ellison, PA Burch, JA Sloan… - … Journal of the …, 2003 - Wiley Online Library
BACKGROUND Recent laboratory and epidemiologic studies have suggested that green tea
has antitumor effects in patients with prostate carcinoma. This Phase II trial explored green …

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and …

A Jatoi, K Rowland, CL Loprinzi, JA Sloan… - Journal of Clinical …, 2004 - ascopubs.org
Purpose Studies suggest eicosapentaenoic acid (EPA), an omega-3 fatty acid, augments
weight, appetite, and survival in cancer-associated wasting. This study determined whether an …

Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival

…, DA Schomas, MS Allen, SD Cassivi, A Jatoi… - The Annals of thoracic …, 2009 - Elsevier
BACKGROUND: Neoadjuvant chemoradiotherapy followed by esophagogastrectomy has
become the standard of care for patients with locally advanced esophageal cancer. This report …

[PDF][PDF] The outcome of combined-modality therapy for stage III non–small-cell lung cancer in the elderly

…, WL McGinnis, JA Mailliard, J Brindle, A Jatoi… - Journal of clinical …, 2003 - Citeseer
Purpose: The North Central Cancer Treatment Group per-formed a phase III trial to determine
whether chemotherapy plus either bid radiation therapy (RT) or daily (qd) RT resulted in a …